Fenfluramine
Fenfluramine hydrochloride is an indirect 5-HT receptor agonist that was used as an anoretic i.e. an appetite reduction drug, sold under the brand name Pondimin.
It was removed from sale in 1997 because of significant safety fears that it contributed to the development of cardiac valvular disease.
Some people believe that it was a beneficial intervention for some of the problems faced by people with autism, although this was disputed by others.
Related Glossaries
Related Publications
There are 17 publications matching this term. Click Here to view the list (New Window).
About This Glossary
This glossary is designed to explain some of the jargon and gobbledygook used by some people when they talk about autism or research..
You may be able to find more information, including links to other parts of this website, by clicking on the title of an item.
If you know of any other items we should include in this section, please email info@informationautism.org.
Please note that we reserve the right not to include an item if we feel that it is not appropriate.
Disclaimer
The fact that an intervention is listed in this glossary does not necessarily mean that we agree with its use. Nor does it necessarily mean that there is any scientifically valid or reliable evidence behind it.